Company: LIDRW
Filing Date: 2025-05-12
Form Type: POS AM
Source: 0000947871-25-000486
Chunk: 4

Company: AEye, Inc.
Filing Date: 2025-05-12
Form: POS AM
Chunk 4
---
 |  1 |
| CAUTIONARY                                      
 STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS |     |  2 |
| PROSPECTUS SUMMARY                              |     |  4 |
| THE OFFERING                                    |     |  7 |
| RISK FACTORS                                    |     |  8 |
| THE NEW CIRCLE TRANSACTION                      |     | 11 |
| USE OF PROCEEDS                                 |     | 14 |
| SELLING                                         
 STOCKHOLDER                                     |     | 15 |
| DESCRIPTION OF CAPITAL STOCK                    |     | 17 |
| PLAN OF DISTRIBUTION                            |     | 22 |
| LEGAL MATTERS                                   |     | 24 |
| EXPERTS                                         |     | 24 |
| WHERE YOU CAN FIND MORE INFORMATION             |     | 25 |
| INFORMATION                                     
 INCORPORATED BY REFERENCE                       |     | 26 |

<div align='center'>ABOUT THIS PROSPECTUS</div>

This prospectus is part of a registration statement
that we filed with the U.S. Securities and Exchange Commission (“ SEC ”) using the “shelf” registration
process. Under the shelf registration process, the Selling Stockholder may, from time to time, sell the securities offered by them described
in this prospectus . We are not selling any securities under this prospectus and will not receive any of the proceeds from the sale
of our Common Stock by the Selling Stockholder, although we will receive proceeds from sales of our Common Stock to New Circle that we
may make pursuant to the Purchase Agreement, as described in this prospectus.

We may also file a prospectus supplement or post-effective
amendment to the registration statement of which this prospectus forms a part that may contain material information relating to these
offerings. The prospectus supplement or post-effective amendment may also add, update, or change information contained in this prospectus
with respect to that offering. If there is any inconsistency between the information in this prospectus and the applicable prospectus
supplement or post-effective amendment, you should rely on the prospectus supplement or post-effective amendment, as applicable. Before
purchasing any of our securities, you should carefully read this prospectus, any post-effective amendment, and any applicable prospectus
supplement, together with the additional information described under the heading “Where You Can Find More Information ”
and “Information Incorporated by Reference .”

Neither we nor the Selling Stockholder have authorized
anyone to provide